Ftse Mib
36.267,63
1,25%
DAX
20.903,39
1,31%
S&P 500
5.996,66
1,00%
NASDAQ
19.630,20
1,51%
Bitcoin
103.101,29
-0,98%
Pepperstone
Advertisement
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Lantheus Holdings Inc (LNTH) Lantheus Holdings Inc (LNTH) Notizie

LNTH

Lantheus (LNTH)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:LNTH
DataOraFonteTitoloSimboloCompagnia
13/01/202506:05GlobeNewswire Inc.Lantheus to Acquire Life Molecular Imaging for an Upfront Payment of $350 Million to Accelerate Innovation for Patients in the Growing Alzheimer’s Disease Radiodiagnostic MarketNASDAQ:LNTHLantheus Holdings Inc
23/12/202422:32Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LNTHLantheus Holdings Inc
20/11/202407:00GlobeNewswire Inc.Lantheus Announces Share Repurchase ProgramNASDAQ:LNTHLantheus Holdings Inc
19/11/202422:39Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LNTHLantheus Holdings Inc
15/11/202417:59Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:LNTHLantheus Holdings Inc
13/11/202414:30GlobeNewswire Inc.Lantheus to Present at the Jefferies London Healthcare ConferenceNASDAQ:LNTHLantheus Holdings Inc
11/11/202413:39GlobeNewswire Inc.Lantheus Continues to Commend CMS’ CY25 Rule to Enhance Payment for Specialized Diagnostic Radiopharmaceuticals and Reaffirms Outlook for PYLARIFY’s Blockbuster Status for 2025NASDAQ:LNTHLantheus Holdings Inc
06/11/202413:42Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:LNTHLantheus Holdings Inc
06/11/202413:00GlobeNewswire Inc.Lantheus Reports Third Quarter 2024 Financial ResultsNASDAQ:LNTHLantheus Holdings Inc
04/11/202413:30GlobeNewswire Inc.Lantheus Applauds CMS’ CY25 Rule to Enhance Payment for Specialized Diagnostic Radiopharmaceuticals, Advancing Patient Access and CareNASDAQ:LNTHLantheus Holdings Inc
23/10/202414:30GlobeNewswire Inc.Lantheus to Host Third Quarter 2024 Earnings Conference Call and Webcast on November 6, 2024, at 8:00 a.m. Eastern TimeNASDAQ:LNTHLantheus Holdings Inc
15/09/202414:45GlobeNewswire Inc.Lantheus Presents Results from the Primary Analysis of Phase 3 Pivotal SPLASH Trial in PSMA-Positive Metastatic Castration-Resistant Prostate Cancer During ESMO Congress 2024NASDAQ:LNTHLantheus Holdings Inc
05/09/202414:30GlobeNewswire Inc.Lantheus Appoints Julie Eastland as New Board MemberNASDAQ:LNTHLantheus Holdings Inc
28/08/202414:30GlobeNewswire Inc.Lantheus to Present at the Morgan Stanley 22nd Annual Global Healthcare ConferenceNASDAQ:LNTHLantheus Holdings Inc
21/08/202422:35Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:LNTHLantheus Holdings Inc
20/08/202414:30GlobeNewswire Inc.Lantheus to Present Additional Clinical Data from Phase 3 Pivotal SPLASH Trial in PSMA-Positive Metastatic Castration-Resistant Prostate Cancer During ESMO Congress 2024NASDAQ:LNTHLantheus Holdings Inc
12/08/202423:04Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:LNTHLantheus Holdings Inc
31/07/202413:00GlobeNewswire Inc.Lantheus Reports Second Quarter 2024 Financial ResultsNASDAQ:LNTHLantheus Holdings Inc
17/07/202414:30GlobeNewswire Inc.Lantheus to Host Second Quarter 2024 Earnings Conference Call and Webcast on July 31, 2024, at 8:00 a.m. Eastern TimeNASDAQ:LNTHLantheus Holdings Inc
15/07/202414:30GlobeNewswire Inc.Lantheus Acquires NAV-4694, a Next-Generation ß Amyloid PET Imaging Agent for Alzheimer’s DiseaseNASDAQ:LNTHLantheus Holdings Inc
10/07/202418:32GlobeNewswire Inc.Lantheus Welcomes CMS’ Proposed CY25 Rule for Improved Payment for Specialized Diagnostic Radiopharmaceuticals to Support Patient AccessNASDAQ:LNTHLantheus Holdings Inc
08/07/202414:30GlobeNewswire Inc.Lantheus Appoints Jamie Spaeth as Chief People OfficerNASDAQ:LNTHLantheus Holdings Inc
27/06/202413:05GlobeNewswire Inc.Lantheus Acquires Global Rights to Life Molecular Imaging’s Novel Therapeutic and Diagnostic Pair Targeting GRPR for Prostate and Breast CancersNASDAQ:LNTHLantheus Holdings Inc
21/06/202402:41GlobeNewswire Inc.Radiopharm Receives Strategic Investment for up to A$18 millionNASDAQ:LNTHLantheus Holdings Inc
03/06/202414:30GlobeNewswire Inc.Lantheus’ AI-Enabled aPROMISE Now Available on Siemens Healthineers’ syngo.via platformNASDAQ:LNTHLantheus Holdings Inc
31/05/202422:30Edgar (US Regulatory)Form SD - Specialized disclosure reportNASDAQ:LNTHLantheus Holdings Inc
28/05/202414:00GlobeNewswire Inc.Lantheus to Present at the William Blair 44th Annual Growth Stock ConferenceNASDAQ:LNTHLantheus Holdings Inc
15/05/202422:30GlobeNewswire Inc.Lantheus Announces Executive Appointments to Accelerate InnovationNASDAQ:LNTHLantheus Holdings Inc
02/05/202413:00GlobeNewswire Inc.Lantheus Reports First Quarter 2024 Financial ResultsNASDAQ:LNTHLantheus Holdings Inc
18/04/202414:00GlobeNewswire Inc.Lantheus to Host First Quarter 2024 Earnings Conference Call and Webcast on May 2, 2024, at 8:00 a.m. Eastern TimeNASDAQ:LNTHLantheus Holdings Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:LNTH

La tua Cronologia

NASDAQ
ZTEK
Zentek
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network